home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
TRACON Pharmaceuticals Announces Pricing of Initial Public Offering
TRACON Pharmaceuticals Announces Pricing of Initial Public Offering
Post navigation
Previous Post
Previous
Cancer biotech TRACON Pharmaceuticals files for a $58 million IPO
Next Post
Next
Blueprint Medicines Appoints Anthony Boral, M.D., Ph.D., as Senior Vice President, Clinical Development